Global Health Ltd.

NSE: MEDANTA | BSE: 543654 | ISIN: INE474Q01031 | Industry: Healthcare Facilities
| Expensive Performer
1174.9000 -26.90 (-2.24%)
NSE Nov 14, 2025 15:31 PM
Volume: 175.5K
 

logo
Global Health Ltd.
06 Oct 2025
1174.90
-2.24%
Business Standard
Global healthcare company Abbott on Monday announced the launch of a dual-chamber leadless pacemaker system, which will help the heart beat properly without wires or surgical pockets used in traditional pacemakers. Pacemakers help keep the heart beating at a healthy pace, especially in the case of bradycardia, a condition where the heart beats too slowly. In a statement, Abbott said its implant-to-implant device technology enables wireless communication and synchronisation between two leadless pacemakers, which are smaller than an AAA battery. Until recently, leadless pacemakers could only support one chamber of the heart, because getting two separate devices to work together in sync was a major challenge. "As leadless pacing technology has evolved, we've built upon our AVEIR VR single-chamber platform to expand the benefits of leadless pacing to far more people and provide additional treatment options to patients," said Ajay Singh Chauhan, General Manager for Abbott's cardiac rhyt
Number of FII/FPI investors increased from 215 to 260 in Sep 2025 qtr.
More from Global Health Ltd.
Recommended